EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.7.12.1 | Adenocarcinoma |
19818968 |
Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 4 4 1 |
2.7.12.1 | Adenocarcinoma |
25712377 |
DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 2 4 |
2.7.12.1 | Adenocarcinoma |
26341817 |
Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma. |
causal interaction diagnostic usage unassigned |
4 2 0 |
2.7.12.1 | Adenocarcinoma |
27532268 |
Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 1 |
2.7.12.1 | Adenocarcinoma |
28502078 |
Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 4 0 |
2.7.12.1 | Adenocarcinoma |
30343272 |
DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. |
causal interaction ongoing research therapeutic application unassigned |
4 4 4 0 |
2.7.12.1 | Adenocarcinoma |
31838052 |
Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A. |
causal interaction therapeutic application unassigned |
4 3 0 |
2.7.12.1 | Adenocarcinoma |
32687947 |
The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 2 1 |
2.7.12.1 | Adenocarcinoma of Lung |
12874018 |
Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas. |
causal interaction diagnostic usage unassigned |
4 2 0 |
2.7.12.1 | Adenocarcinoma of Lung |
33368138 |
Frequent DYRK2 gene amplification in micropapillary element of lung adenocarcinoma - an implication in progression in EGFR-mutated lung adenocarcinoma. |
diagnostic usage ongoing research therapeutic application unassigned |
2 2 1 0 |